The combination of antiangiogenic therapy with other modalities.

Cancer journal (Sudbury, Mass.)

Volumn 8 Suppl 1, Issue , 2002, Pages

  O'Reilly, Michael S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

DRUG EFFECT; HUMAN; MULTIMODALITY CANCER THERAPY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0036579996     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)